Investigating the impact of alpha/beta and LETd on relative biological effectiveness in scanned proton beams: An in vitro study based on human cell lines
Open Access
- 29 April 2020
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 47 (8), 3691-3702
- https://doi.org/10.1002/mp.14212
Abstract
Purpose A relative biological effectiveness (RBE) of 1.1 is commonly used in clinical proton therapy, irrespective of tissue type and depth. This in‐vitro study was conducted to quantify the RBE of scanned protons as a function of the dose‐averaged linear energy transfer (LETd) and the sensitivity factor (α/ß)X. Additionally, three phenomenological models (McNamara, Rørvik and Jones) and one mechanistic model (Repair‐Misrepair‐Fixation, RMF) were applied to the experimentally derived data. Methods Four human cell lines (FaDu, HaCat, Du145, SKMel) with differential (α/ß)X ratios were irradiated in a custom‐designed irradiation set‐up with doses between 0 and 6 Gy at proximal, central and distal positions of a 80 mm spread‐out Bragg peak (SOBP) centered at 80 mm (set‐up A: proton energies 66.5‐135.6 MeV) and 155 mm (set‐up B: proton energies 127.2‐185.9 MeV) depth, respectively. LETd values at the respective cell positions were derived from Monte Carlo simulations performed with the treatment planning system (TPS, RayStation). Dosimetric measurements were conducted to verify dose homogeneity and dose delivery accuracy. RBE values were derived for doses that resulted in 90 % (RBE90) and 10 % (RBE10) of cell survival, and survival after a 0.5 Gy dose (RBE0.5Gy), 2 Gy dose (RBE2Gy) and 6 Gy dose (RBE6Gy). Results LETd values at sample positions were 1.9, 2.1, 2.5, 2.8, 4.1 and 4.5 keV/µm. For the cell lines with high (α/ß)X ratios (FaDu, HaCat), the LETd did not impact on the RBE. For low (α/ß)X cell lines (Du145, SKMel), LQ‐derived survival curves indicated a clear correlation of LETd and RBE. RBE90 values up to 2.9 and RBE10 values between 1.4 and 1.8 were obtained. Model‐derived RBE predictions slightly overestimated the RBE for the high (α/ß)X cell lines, although all models except the Jones model provided RBE values within the experimental uncertainty. For low (α/ß)X cell lines, no agreement was found between experiments and model predictions, i.e. all models underestimated the measured RBE. Conclusions The sensitivity parameter (α/ß)X was observed to be a major influencing factor for the RBE of protons and its sensitivity towards LETd changes. RBE prediction models are applicable for high (α/ß)X cell lines but do not estimate RBE values with sufficient accuracy in low (α/ß)X cell lines.Keywords
This publication has 56 references indexed in Scilit:
- 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testingBMC Cancer, 2013
- Variations in the RBE for Cell Killing Along the Depth-Dose Profile of a Modulated Proton Therapy BeamRadiation Research, 2013
- Development of Multicellular Tumor Spheroid (MCTS) Culture from Breast Cancer Cell and a High Throughput Screening Method Using the MTT AssayPLOS ONE, 2012
- Isoeffective dose: a concept for biological weighting of absorbed dose in proton and heavier-ion therapiesRadiation Protection Dosimetry, 2010
- Multicellular tumor spheroids: An underestimated tool is catching up againJournal of Biotechnology, 2010
- Particle Radiation Therapy Using Proton and Heavier Ion BeamsJournal of Clinical Oncology, 2007
- The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and unitsRadiation Protection Dosimetry, 2006
- Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beamInternational Journal of Radiation Biology, 2006
- On the surviving fraction in irradiated multicellular tumour spheroids: calculation of overall radiosensitivity parameters, influence of hypoxia and volume effectsPhysics in Medicine & Biology, 2005
- In vivo determinations of RBE in a high energy modulated proton beam using normal tissue reactions and fractionated dose schedulesInternational Journal of Radiation Oncology*Biology*Physics, 1977